Remove Angioplasty Remove Diabetes Remove Stenosis
article thumbnail

Impact of Diabetes on Outcomes in Left Main Coronary Revascularization: PCI vs. CABG

Cardiology Update

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes.

Diabetes 122
article thumbnail

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Circulation

Patients were categorized by diabetes status. Kaplan-Meier event rates, Cox model hazard ratios, and interactions were assessed.RESULTS:Among 4393 patients, 1104 (25.1%) had diabetes. Kaplan-Meier event rates, Cox model hazard ratios, and interactions were assessed.RESULTS:Among 4393 patients, 1104 (25.1%) had diabetes.

article thumbnail

Medtronic Presents New Data, Clinical Milestones at CRT 2025

DAIC

Sacharias von Kochpresented " Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons" This is atwo-year analysis from the Swedish Coronary Angiography and Angioplasty (SCAAR) Registry in more than 6,000 patients. Prevail DCB is limited to investigational use in the U.S.

article thumbnail

Abstract WMP94: Trends in Co-morbidities and Mortality in Rescue Stenting and Elective Stenting for Intracranial Atherosclerotic Disease: National Inpatient Sample Data Analysis

Stroke Journal

National Inpatient Sample (NIS) database from 2009 to 2020, evaluating patients who presented with stroke from ICAD and were treated with angioplasty and stenting and analyzed presenting co-morbidities and patient outcomes. vs 7.9%), diabetes (33.6% There were significantly higher incidences in uncontrolled hypertension (28.2%

Stent 40
article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. 12:15 p.m.

article thumbnail

Medtronic Presents New Data, Clinical Milestones

DAIC

Sacharias von Kochpresented " Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared with Other Contemporary Drug-Coated Balloons" This is atwo-year analysis from the Swedish Coronary Angiography and Angioplasty (SCAAR) Registry in more than 6,000 patients. Prevail DCB is limited to investigational use in the U.S.

article thumbnail

Abstract 107: Endovascular Therapy for Tandem Vertebral and Basilar Artery Occlusion in a Patient with Low NIHSS

Stroke: Vascular and Interventional Neurology

Patient underwent emergent mechanical thrombectomy with ADAPT to TICI3 revascularization with future plan for possible angioplasty and stenting of R vertebral stenosis. CT perfusion was without mismatch. Subsequently admitted to neurocritical care unit and treated with dual antiplatelet therapy.